DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Software
Updated 2h ago
TAOX logo

TAO Synergies Inc.NasdaqCM:TAOX Stock Report

Market Cap US$29.2m
Updated 2h ago
Share Price
n/a
1Y-39.2%
7D-8.6%
1D-6.0%
Portfolio Value
​
View

TAO Synergies Inc.

NasdaqCM:TAOX Stock Report

Market Cap: US$29.2m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

TAO Synergies (TAOX) Stock Overview

Owns and operates an AI token. More details

TAOX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue ($772K)

Has less than 1 year of cash runway

Earnings have declined by 18.4% per year over past 5 years

+ 1 more risk

TAOX Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW445,219 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
445,219 investors already sharing narratives
US$
Current Price
US$3.67141.1% overvalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-66m24m2016201920222025202620282031Revenue US$23.7mEarnings US$2.9m
Advanced
View all narratives

TAO Synergies Inc. Competitors

Nightfood Holdings

Symbol: OTCPK:NGTF
Market cap: US$14.3m

NextTrip

Symbol: NasdaqCM:NTRP
Market cap: US$22.5m

Infobird

Symbol: NasdaqCM:IFBD
Market cap: US$8.1m

TON Strategy

Symbol: NasdaqCM:TONX
Market cap: US$175.1m

Price History & Performance

Summary of share price highs, lows and changes for TAO Synergies
Historical stock prices
Current Share PriceUS$3.67
52 Week HighUS$10.00
52 Week LowUS$3.07
Beta1.5
1 Month Change6.54%
3 Month Change-4.56%
1 Year Change-39.22%
3 Year Change-49.47%
5 Year Change-98.33%
Change since IPO-95.74%

Recent News & Updates

Analysis Article • Jul 30

Companies Like TAO Synergies (NASDAQ:TAOX) Could Be Quite Risky

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article • Apr 07

Is TAO Synergies (NASDAQ:TAOX) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Recent updates

Analysis Article • Jul 30

Companies Like TAO Synergies (NASDAQ:TAOX) Could Be Quite Risky

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article • Apr 07

Is TAO Synergies (NASDAQ:TAOX) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Oct 13

TAO Synergies (NASDAQ:TAOX) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Sep 20

We Think Synaptogenix (NASDAQ:SNPX) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Analysis Article • May 10

Companies Like Synaptogenix (NASDAQ:SNPX) Are In A Position To Invest In Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Seeking Alpha • Nov 17

Synaptogenix: High-Risk High-Reward For Potential Alzheimer's Disease Treatment

SNPX did not achieve primary endpoints in two Phase 2 studies for Bryostatin for the treatment of Alzheimer’s Disease in moderately severe to severe patients. Post-hoc analysis of 95 patients from these two studies with MMSE 10-15, and not taking Namenda, revealed a statistically significant improvement vs placebo. Based on learnings from the first two trials, a third trial is underway with a longer duration (6 vs 3 months) and a narrowed patient population – read-out targeted for 2H2022. The probability of success in the current trial is reasonable based on the learnings from the first two trials, but the small size is a risk that a statistically-significant improvement may not be achieved. The potential large upside affords a highly positive asymmetric risk-reward.
Analysis Article • Oct 05

Synaptogenix (NASDAQ:SNPX) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analysis Article • Jun 09

We're Keeping An Eye On Synaptogenix's (NASDAQ:SNPX) Cash Burn Rate

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Shareholder Returns

TAOXUS SoftwareUS Market
7D-8.6%0.8%-1.5%
1Y-39.2%-8.3%13.3%

Return vs Industry: TAOX underperformed the US Software industry which returned -8.3% over the past year.

Return vs Market: TAOX underperformed the US Market which returned 13.3% over the past year.

Price Volatility

Is TAOX's price volatile compared to industry and market?
TAOX volatility
TAOX Average Weekly Movement9.6%
Software Industry Average Movement9.4%
Market Average Movement6.9%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: TAOX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: TAOX's weekly volatility has decreased from 16% to 10% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20125n/ataosynergies.com

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.

TAO Synergies Inc. Fundamentals Summary

How do TAO Synergies's earnings and revenue compare to its market cap?
TAOX fundamental statistics
Market capUS$29.18m
Earnings (TTM)-US$21.35m
Revenue (TTM)US$772.50k
35.5x
P/S Ratio
-1.3x
P/E Ratio

Is TAOX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TAOX income statement (TTM)
RevenueUS$772.50k
Cost of RevenueUS$0
Gross ProfitUS$772.50k
Other ExpensesUS$22.12m
Earnings-US$21.35m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-2.85
Gross Margin100.00%
Net Profit Margin-2,763.47%
Debt/Equity Ratio0%

How did TAOX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/15 21:30
End of Day Share Price 2026/09/15 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TAO Synergies Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason McCarthyMaxim Group

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide